| Sean Hostmeyer, MD | |
|
100 N Academy Ave, Danville, PA 17822-1576 | |
| (570) 271-6301 | |
| (570) 271-5976 |
| Full Name | Sean Hostmeyer |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 9 Years |
| Location | 100 N Academy Ave, Danville, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104210673 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD474252 (Pennsylvania) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | DR.0070427 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Colorado Hospital Authority | Aurora, CO | Hospital |
| Denver Health & Hospital Authority | Denver, CO | Hospital |
| Uchealth Highlands Ranch Hospital | Highlands ranch, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
| Denver Health And Hospital Authority | 4688583578 | 650 |
| Uchealth Imaging Services Llc | 5799021291 | 141 |
News Archive
Underwriters Laboratories (UL), a world leader in safety testing and certification, announced today the release of a white paper that addresses the current and anticipated regulatory landscape for manufacturers of home healthcare equipment. The white paper, "Home Healthcare Equipment: An Overview," examines the new IEC 60601-1-11 standard, and highlights the unique challenges for manufacturers with the U.S. Food and Drug Administration's (FDA) recently announced Medical Device Home Initiative.
In the past, the only options for removing tattoos were dermabrasion and excision – neither was entirely effective and both were painful. But thanks to the latest advancements in science and technology, there are now pigment-specific lasers that can target more colors than ever before.
DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy.
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
› Verified 9 days ago
| Entity Name | Denver Health And Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211 |
News Archive
Underwriters Laboratories (UL), a world leader in safety testing and certification, announced today the release of a white paper that addresses the current and anticipated regulatory landscape for manufacturers of home healthcare equipment. The white paper, "Home Healthcare Equipment: An Overview," examines the new IEC 60601-1-11 standard, and highlights the unique challenges for manufacturers with the U.S. Food and Drug Administration's (FDA) recently announced Medical Device Home Initiative.
In the past, the only options for removing tattoos were dermabrasion and excision – neither was entirely effective and both were painful. But thanks to the latest advancements in science and technology, there are now pigment-specific lasers that can target more colors than ever before.
DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy.
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
› Verified 9 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
Underwriters Laboratories (UL), a world leader in safety testing and certification, announced today the release of a white paper that addresses the current and anticipated regulatory landscape for manufacturers of home healthcare equipment. The white paper, "Home Healthcare Equipment: An Overview," examines the new IEC 60601-1-11 standard, and highlights the unique challenges for manufacturers with the U.S. Food and Drug Administration's (FDA) recently announced Medical Device Home Initiative.
In the past, the only options for removing tattoos were dermabrasion and excision – neither was entirely effective and both were painful. But thanks to the latest advancements in science and technology, there are now pigment-specific lasers that can target more colors than ever before.
DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy.
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
› Verified 9 days ago
| Entity Name | Uchealth Imaging Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396210902 PECOS PAC ID: 5799021291 Enrollment ID: O20190103002022 |
News Archive
Underwriters Laboratories (UL), a world leader in safety testing and certification, announced today the release of a white paper that addresses the current and anticipated regulatory landscape for manufacturers of home healthcare equipment. The white paper, "Home Healthcare Equipment: An Overview," examines the new IEC 60601-1-11 standard, and highlights the unique challenges for manufacturers with the U.S. Food and Drug Administration's (FDA) recently announced Medical Device Home Initiative.
In the past, the only options for removing tattoos were dermabrasion and excision – neither was entirely effective and both were painful. But thanks to the latest advancements in science and technology, there are now pigment-specific lasers that can target more colors than ever before.
DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy.
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean Hostmeyer, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Sean Hostmeyer, MD 100 N Academy Ave, Danville, PA 17822-1576 Ph: (570) 271-6301 |
News Archive
Underwriters Laboratories (UL), a world leader in safety testing and certification, announced today the release of a white paper that addresses the current and anticipated regulatory landscape for manufacturers of home healthcare equipment. The white paper, "Home Healthcare Equipment: An Overview," examines the new IEC 60601-1-11 standard, and highlights the unique challenges for manufacturers with the U.S. Food and Drug Administration's (FDA) recently announced Medical Device Home Initiative.
In the past, the only options for removing tattoos were dermabrasion and excision – neither was entirely effective and both were painful. But thanks to the latest advancements in science and technology, there are now pigment-specific lasers that can target more colors than ever before.
DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy.
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
› Verified 9 days ago
Dr. Tana M. Shaffer, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 | |
Leslie C. Scott, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-560-1628 Fax: 570-560-1628 | |
Dr. Mary L. Strickland, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 | |
Clara Jean Chudow, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 Fax: 570-271-5976 | |
Dr. Faruq Mahmud, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 | |
Dr. Marta J. Carleton, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 | |
Arbab Iqbal, Radiology Medicare: Accepting Medicare Assignments Practice Location: Geisinger Medical Ctr, 100 North Academy Avenue, Danville, PA 17822 Phone: 570-271-6211 |